Insider Buy/Sell Details for the Biotechnology Industry — Last 3 Months
Ratio0.1:1
Daily Buy & Sell Volume
Transactions (3383)
Grace Therapeutics, Inc. (GRCE)
Kohli Prashant — Director
Shares
100,000
Price
$2.14
Total Value
$214.00K
Shares Held After
121,357
% of Holdings
82.4%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
3,097
Price
$68.70
Total Value
$212.78K
Shares Held After
536,876
% of Holdings
0.6%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
28,837
Price
$7.13
Total Value
$205.61K
Shares Held After
3,885,115
% of Holdings
0.7%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
28,837
Price
$7.13
Total Value
$205.61K
Shares Held After
3,885,115
% of Holdings
0.7%
Vaxcyte, Inc. (PCVX)
Wassil Jim — EVP, Chief Scientific Ofc, COO
Shares
1,334
Price
$59.52
Total Value
$79.40K
Shares Held After
145,435
% of Holdings
0.9%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
36,000
Price
$97.78
Total Value
$3.52M
Shares Held After
708,709
% of Holdings
4.8%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
273,290
Price
$10.63
Total Value
$2.90M
Shares Held After
2,298,783
% of Holdings
11.9%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
273,291
Price
$10.63
Total Value
$2.90M
Shares Held After
4,937,026
% of Holdings
5.5%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
48,065
Price
$10.55
Total Value
$507.01K
Shares Held After
2,025,493
% of Holdings
2.3%
ALUMIS INC. (ALMS)
AKKARAJU SRINIVAS — Director
Shares
48,066
Price
$10.55
Total Value
$507.02K
Shares Held After
4,663,735
% of Holdings
1.0%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
2,700
Price
$198.09
Total Value
$534.84K
Shares Held After
70,134
% of Holdings
3.7%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
8,752
Price
$197.36
Total Value
$1.73M
Shares Held After
72,834
% of Holdings
10.7%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
6,058
Price
$196.54
Total Value
$1.19M
Shares Held After
81,586
% of Holdings
6.9%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
6,090
Price
$195.62
Total Value
$1.19M
Shares Held After
87,644
% of Holdings
6.5%
BELITE BIO, INC (BLTE)
Lin Yu-Hsin — Director
Shares
2,400
Price
$194.33
Total Value
$466.40K
Shares Held After
93,734
% of Holdings
2.5%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
2,562
Price
$198.05
Total Value
$507.39K
Shares Held After
26,038
% of Holdings
9.0%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
4,605
Price
$197.23
Total Value
$908.24K
Shares Held After
28,600
% of Holdings
13.9%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
4,475
Price
$196.47
Total Value
$879.20K
Shares Held After
33,205
% of Holdings
11.9%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
4,120
Price
$195.60
Total Value
$805.89K
Shares Held After
37,680
% of Holdings
9.9%
BELITE BIO, INC (BLTE)
Chuang Hao-Yuan — Director
Shares
2,200
Price
$194.28
Total Value
$427.41K
Shares Held After
41,800
% of Holdings
5.0%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
471
Price
$69.37
Total Value
$32.67K
Shares Held After
533,779
% of Holdings
0.1%
Sol-Gel Technologies Ltd. (SLGL)
Opaleye Management Inc. — 10% Owner
Shares
3,390
Price
$68.74
Total Value
$233.03K
Shares Held After
533,308
% of Holdings
0.6%
Entrada Therapeutics, Inc. (TRDA)
MPM BioVentures 2014, L.P. — 10% Owner
Shares
192,500
Price
$7.41
Total Value
$1.43M
Shares Held After
3,913,952
% of Holdings
4.7%
Entrada Therapeutics, Inc. (TRDA)
MPM BIOVENTURES 2018, L.P. — 10% Owner
Shares
192,500
Price
$7.41
Total Value
$1.43M
Shares Held After
3,913,952
% of Holdings
4.7%
Harmony Biosciences Holdings, Inc. (HRMY)
Budur Kumar — CHIEF MEDICAL OFFICER
Shares
22,954
Price
$43.10
Total Value
$989.35K
Shares Held After
13,115
% of Holdings
63.6%
Harmony Biosciences Holdings, Inc. (HRMY)
Budur Kumar — CHIEF MEDICAL OFFICER
Shares
1,000
Price
$42.79
Total Value
$42.79K
Shares Held After
13,115
% of Holdings
7.1%
Harmony Biosciences Holdings, Inc. (HRMY)
Budur Kumar — CHIEF MEDICAL OFFICER
Shares
4,500
Price
$42.25
Total Value
$190.11K
Shares Held After
14,115
% of Holdings
24.2%
BioNTech SE (BNTX)
Sahin Ugur — Chief Executive Officer
Shares
37,000
Price
$99.20
Total Value
$3.67M
Shares Held After
744,709
% of Holdings
4.7%
Ascendis Pharma A/S (ASND)
Bodenhoff Mads — SVP&PAO
Shares
3,000
Price
$270.19
Total Value
$810.57K
Shares Held After
0
% of Holdings
100.0%
Relay Therapeutics, Inc. (RLAY)
Patel Sanjiv — Director
Shares
48,199
Price
$18.94
Total Value
$912.89K
Shares Held After
519,500
% of Holdings
8.5%
Century Therapeutics, Inc. (IPSC)
Carr Douglas — SVP Finance&Operations
Shares
254
Price
$2.05
Total Value
$520.70
Shares Held After
504,565
% of Holdings
0.1%
Relay Therapeutics, Inc. (RLAY)
Catinazzo Thomas — Chief Financial Officer
Shares
17,717
Price
$18.94
Total Value
$335.56K
Shares Held After
122,851
% of Holdings
12.6%
Century Therapeutics, Inc. (IPSC)
Russotti Gregory — Chief Technology and Manufacturing Officer
Shares
534
Price
$2.05
Total Value
$1.09K
Shares Held After
511,785
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
418
Price
$504.15
Total Value
$210.73K
Shares Held After
324,443
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
701
Price
$503.33
Total Value
$352.83K
Shares Held After
324,861
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,167
Price
$502.26
Total Value
$586.13K
Shares Held After
325,562
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,221
Price
$501.17
Total Value
$611.93K
Shares Held After
326,729
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,173
Price
$500.20
Total Value
$586.73K
Shares Held After
327,950
% of Holdings
0.4%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,018
Price
$498.77
Total Value
$507.75K
Shares Held After
329,123
% of Holdings
0.3%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
1,902
Price
$498.18
Total Value
$947.53K
Shares Held After
330,141
% of Holdings
0.6%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
300
Price
$497.05
Total Value
$149.12K
Shares Held After
332,043
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
256
Price
$495.75
Total Value
$126.91K
Shares Held After
332,343
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
600
Price
$494.87
Total Value
$296.92K
Shares Held After
332,599
% of Holdings
0.2%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
144
Price
$493.98
Total Value
$71.13K
Shares Held After
333,199
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
140
Price
$492.72
Total Value
$68.98K
Shares Held After
333,343
% of Holdings
0.0%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
220
Price
$491.04
Total Value
$108.03K
Shares Held After
333,483
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
200
Price
$483.90
Total Value
$96.78K
Shares Held After
333,703
% of Holdings
0.1%
UNITED THERAPEUTICS Corp (UTHR)
ROTHBLATT MARTINE A — Director
Shares
40
Price
$481.91
Total Value
$19.28K
Shares Held After
333,903
% of Holdings
0.0%
Relay Therapeutics, Inc. (RLAY)
Bergstrom Donald A — President, R&D
Shares
8,530
Price
$18.97
Total Value
$161.81K
Shares Held After
399,130
% of Holdings
2.1%
Rapport Therapeutics, Inc. (RAPP)
Ceesay Abraham — Director
Shares
1,069
Price
$46.01
Total Value
$49.19K
Shares Held After
458,977
% of Holdings
0.2%
Showing 1–50 of 3383 transactions (page 1 of 68)